Your browser is no longer supported. Please, upgrade your browser.
Settings
PACB Pacific Biosciences of California, Inc. daily Stock Chart
PACB [NASD]
Pacific Biosciences of California, Inc.
Index- P/E- EPS (ttm)-0.73 Insider Own0.70% Shs Outstand146.62M Perf Week-0.83%
Market Cap1.05B Forward P/E- EPS next Y-0.50 Insider Trans-2.38% Shs Float141.08M Perf Month-1.52%
Income-92.50M PEG- EPS next Q-0.13 Inst Own85.40% Short Float9.81% Perf Quarter-6.80%
Sales84.00M P/S12.45 EPS this Y-4.60% Inst Trans8.63% Short Ratio6.55 Perf Half Y66.59%
Book/sh0.98 P/B7.28 EPS next Y26.50% ROA-59.60% Target Price6.67 Perf Year188.66%
Cash/sh0.79 P/C9.03 EPS next 5Y30.00% ROE-91.10% 52W Range2.02 - 7.84 Perf YTD-3.65%
Dividend- P/FCF- EPS past 5Y12.40% ROI-90.10% 52W High-9.06% Beta2.42
Dividend %- Quick Ratio5.70 Sales past 5Y29.20% Gross Margin34.30% 52W Low252.97% ATR0.13
Employees456 Current Ratio6.60 Sales Q/Q-22.60% Oper. Margin- RSI (14)48.96 Volatility1.30% 1.97%
OptionableYes Debt/Eq0.00 EPS Q/Q2.60% Profit Margin- Rel Volume0.33 Prev Close7.08
ShortableYes LT Debt/Eq0.11 EarningsFeb 21 AMC Payout- Avg Volume2.11M Price7.13
Recom2.70 SMA200.42% SMA50-2.13% SMA20040.27% Volume697,838 Change0.71%
Oct-19-18Initiated Cowen Outperform
Nov-03-17Downgrade First Analysis Sec Overweight → Equal-Weight $4
Sep-28-17Downgrade CL King Buy → Neutral
Nov-03-16Reiterated Cantor Fitzgerald Buy $18 → $15
Jun-27-16Initiated CL King Buy
Apr-15-16Initiated First Analysis Sec Overweight $11
Feb-04-16Downgrade Piper Jaffray Overweight → Neutral
Jan-04-16Reiterated Cantor Fitzgerald Buy $11 → $18
Oct-23-15Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15Initiated Cantor Fitzgerald Buy
Feb-04-15Reiterated Maxim Group Buy $10 → $11
Sep-26-13Reiterated Maxim Group Buy $4 → $8
Jan-14-13Reiterated Maxim Group Buy $3 → $4
Apr-19-11Initiated William Blair Mkt Perform
Mar-17-11Initiated Oppenheimer Perform $15
Dec-06-10Initiated Deutsche Bank Buy $18
Feb-12-19 10:01AM  Pacific Biosciences (PACB) Incurs Q4 Loss, Revenues Fall Y/Y Zacks
Feb-11-19 06:20PM  Pacific Biosciences of California (PACB) Reports Q4 Loss, Lags Revenue Estimates Zacks
05:23PM  Pacific Biosciences: 4Q Earnings Snapshot Associated Press
04:01PM  Pacific Biosciences Announces Fourth Quarter and Annual 2018 Financial Results GlobeNewswire
Feb-03-19 09:00AM  5 Things to Expect From Illumina in 2019 Motley Fool
Jan-31-19 10:31AM  Pacific Biosciences of California (PACB) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jan-17-19 07:40AM  Report: Exploring Fundamental Drivers Behind SkyWest, Pacific Biosciences of California, Lennar, Regeneron Pharmaceuticals, MGM Growth Properties, and Cincinnati Bell New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jan-04-19 08:27AM  LMNX or PACB: Which is a Better MedTech Investment Pick? Zacks
Dec-31-18 10:51AM  Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Red Hat, LSC Communications, Intersections, and Pacific Biosciences on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
Dec-18-18 03:40PM  INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Acquisition Of Pacific Biosciences of California, Inc. Scheduled For A Shareholder Vote On January 24, 2019 PACB ACCESSWIRE
Dec-12-18 11:55PM  Wolf Haldenstein Adler Freeman & Herz LLP announces that it has filed a class action complaint in the United States District Court for the Northern District of California on behalf of holders of Pacific Biosciences of California, Inc. GlobeNewswire
Dec-10-18 05:06PM  Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Pacific Biosciences of California, Inc. (PACB) on Behalf of Stockholders and Encourages PACB Investors to Contact the Firm GlobeNewswire
Dec-07-18 02:04PM  PACIFIC BIOSCIENCES OF CALIFORNIA, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Business Wire
Dec-06-18 09:39PM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Pacific Biosciences of California, Inc. - PACB PR Newswire
08:44AM  Here's Why You Should Hold Pacific Biosciences (PACB) Now Zacks
Nov-16-18 08:35AM  Here's Why You Should Invest in Illumina (ILMN) Stock Now Zacks
Nov-15-18 10:02AM  Pacific Biosciences Offers Insights on Aedes aegypti Genome Zacks
Nov-14-18 02:26PM  Is This the Real Reason Illumina Acquired Pacific Biosciences? Motley Fool
01:00PM  PacBios SMRT Sequencing Provides Unprecedented Insight into Genome of Disease-causing Mosquito GlobeNewswire
Nov-12-18 07:05AM  Pacific Biosciences Agrees to be Acquired in an All Cash Transaction, Analysts Review ACCESSWIRE
Nov-08-18 04:55PM  Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A Motley Fool
Nov-07-18 10:09AM  Pacific Biosciences (PACB) Reports Q3 Loss, Revenues Fall Y/Y Zacks
09:34AM  Illumina (ILMN) Inks $1.2B Deal to Buy Pacific Biosciences Zacks
07:45AM  Consolidated Research: 2018 Summary Expectations for Pacific Biosciences of California, NXP Semiconductors N.V., Consolidated Communications, Alexander & Baldwin, Willdan Group, and OneMain Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-06-18 09:30AM  Big Biotech May Be After These Technologies ACCESSWIRE
Nov-03-18 02:01PM  Here's Why Illimuna Just Bought Its Biggest Competitor Motley Fool
Nov-02-18 04:47PM  Apple and Kraft Heinz drop while Starbucks and Symantec rise Associated Press +67.63%
04:28PM  Why Newell Brands, VeriSign, and Pacific Biosciences of California Jumped Today Motley Fool
11:00AM  Why Pacific Biosciences of California Stock Is Skyrocketing Today Motley Fool
10:30AM  Surge In Healthcare Growth Sees Rally In These 3 Stocks On Friday ACCESSWIRE
08:32AM  Illumina Buys Rival Pacific Biosciences In $1.2B Deal Benzinga
08:01AM  The Daily Biotech Pulse: Illumina Snaps Up Pacific Bioscience, Thumbs Down For Alkermes Depressive Disorder Drug Benzinga
07:30AM  Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates Zacks
06:01AM  Pacific Biosciences of California Reports a Dismal Quarter -- and a Delightful Acquisition Motley Fool
05:13AM  Pacific Biosciences: 3Q Earnings Snapshot Associated Press
Nov-01-18 05:49PM  Illumina Inc. to buy Menlo Park-based biotech firm for $1.2 billion American City Business Journals
05:07PM  Illumina to buy rival Pacific Biosciences in $1.2 bln deal Reuters
04:18PM  Gene sequencing company Illumina to buy Pacific Biosciences in $1.2 billion deal Reuters
04:16PM  Illumina to acquire Pacific Biosciences for $1.2 billion in cash MarketWatch
04:15PM  Pacific Biosciences of California, Inc. Announces Third Quarter 2018 Financial Results GlobeNewswire
04:13PM  Gene sequencing company Illumina to buy Pacific Biosciences in $1.2 bln deal Reuters
04:02PM  Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery Business Wire
Oct-18-18 09:52AM  Pacific Biosciences Introduces Enhancements to Sequel System Zacks
Oct-16-18 01:25PM  Pacific Biosciences of California, Inc. Third Quarter 2018 Financial Results Call GlobeNewswire +6.94%
Oct-15-18 07:30AM  PacBio Long-Read Sequencing Featured at ASHG Annual Meeting GlobeNewswire
Oct-10-18 08:50AM  Analysis: Positioning to Benefit within Air Products and Chemicals, Harsco, Pioneer Energy Services, Pacific Biosciences of California, Electronic Arts, and PriceSmart Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire -5.18%
07:30AM  Pacific Biosciences Announces a New Paradigm in DNA Sequencing Highly Accurate Single-Molecule Long Reads GlobeNewswire
Oct-08-18 07:30AM  Pacific Biosciences Releases Highest-Quality, Most Contiguous Individual Human Genome Assembly to Date GlobeNewswire
Sep-14-18 10:03AM  Pacific Biosciences (PACB) Up as VGP Picks Flagship Sequel Zacks
08:41AM  Pacific Biosciences (PACB) Jumps: Stock Rises 5.4% Zacks
Sep-13-18 08:00AM  Large-Scale Global Genome Projects Choose PacBio Sequencing to Help Decode Life GlobeNewswire +5.35%
Sep-12-18 08:46AM  Is the Options Market Predicting a Spike in Pacific Biosciences (PACB) Stock? Zacks +6.46%
12:10AM  Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock GlobeNewswire
Sep-11-18 02:16PM  Why Pacific Biosciences Fell By 10.6% Earlier Today Motley Fool
Sep-10-18 04:01PM  Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Sep-06-18 02:13PM  Is Pacific Biosciences of California Inc (NASDAQ:PACB) A Financially Sound Company? Simply Wall St.
Aug-19-18 01:34AM  Edited Transcript of PACB earnings conference call or presentation 2-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-14-18 06:13PM  Will This Biotech Stock Join the $1,000 Human Genome Club in Early 2019? Motley Fool
Aug-10-18 08:54AM  Pacific Biosciences' Sequel Sees Solid Q2, Competition Rife Zacks
Aug-06-18 08:20AM  Detailed Research: Economic Perspectives on Allete, Sterling Construction, Illumina, PROS, Altra Industrial Motion, and Pacific Biosciences of California What Drives Growth in Today's Competitive Landscape GlobeNewswire
Aug-03-18 09:58AM  Pacific Biosciences (PACB) Loss In Line With Estimates in Q2 Zacks
08:18AM  Pacific Biosciences of California Revenue Up Thanks to More System Installs Motley Fool
07:52AM  The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings Benzinga
Aug-02-18 07:15PM  Pacific Biosciences of California (PACB) Reports Q2 Loss, Misses Revenue Estimates Zacks
06:11PM  Pacific Biosciences: 2Q Earnings Snapshot Associated Press
04:01PM  Pacific Biosciences of California, Inc. Announces Second Quarter 2018 Financial Results GlobeNewswire
02:30PM  Pacific Biosciences of California, Inc. to Host Earnings Call ACCESSWIRE
Jul-31-18 09:15AM  Pacific Biosciences Appoints Christian Henry to Board of Directors GlobeNewswire +7.65%
Jul-27-18 05:57PM  Here's Why Pacific Biosciences Tumbled 10% Today Motley Fool -10.07%
11:21AM  What's in Store for Pacific Biosciences' (PACB) Q2 Earnings? Zacks
07:27AM  Moving Average Crossover Alert: Pacific Biosciences of California (PACB) Zacks
Jul-23-18 02:11PM  Pacific Biosciences of California, Inc. Second Quarter 2018 Financial Results Call GlobeNewswire
Jul-18-18 07:45AM  Initiating Free Research Reports on Pieris Pharma and Three Other Biotech Equities ACCESSWIRE
Jul-10-18 07:30AM  Pacific Biosciences Selected for NSF Project to Rapidly Sequence Maize Pangenome GlobeNewswire
Jul-09-18 01:37PM  Here's Why Pacific Biosciences of California, Inc. Rose 40.3% in June Motley Fool
Jun-27-18 11:37AM  Researchers Of Newly Discovered European Cavefish Awarded Genome Sequencing Grant From Pacific Biosciences And GENEWIZ PR Newswire -5.22%
10:54AM  Researchers Of Newly Discovered European Cavefish Awarded Genome Sequencing Grant From Pacific Biosciences And GENEWIZ PR Newswire
Jun-25-18 04:17PM  Why Pacific Biosciences of California Inc. Plunged Today Motley Fool -5.74%
Jun-24-18 09:33AM  Pacific Biosciences of California Incs (NASDAQ:PACB) Earnings Dropped -17.25%, How Did It Fare Against The Industry? Simply Wall St.
Jun-22-18 08:17AM  Better Buy: Illumina, Inc. vs. Pacific Biosciences of California Motley Fool
Jun-11-18 09:49AM  Pacific Biosciences to Gain From New Genome Sequencing Tools Zacks +6.38%
Jun-08-18 02:37PM  Is This Why Pacific Biosciences of California Surged This Week? Motley Fool
Jun-07-18 07:30AM  Pacific Biosciences Launches Microbial Multiplexing Kit, New SMRT Grant Program GlobeNewswire +11.03%
Jun-06-18 04:00AM  Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria GlobeNewswire
Jun-01-18 10:50AM  Why Is Pacific Biosciences (PACB) Down 6.7% Since its Last Earnings Report? Zacks
May-08-18 05:00PM  Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore GlobeNewswire
May-07-18 05:15AM  Edited Transcript of PACB earnings conference call or presentation 2-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-03-18 12:47PM  Here's Why Pacific Biosciences of California Is Falling Today Motley Fool -11.75%
11:02AM  For Pacific Biosciences of California, a First Quarter Hurt by Shipment Delays Motley Fool
10:22AM  Pacific Biosciences (PACB) Loss Wider Than Expected in Q1 Zacks
08:31AM  Benzinga's Daily Biotech Pulse: Achaogen Slumps On Mixed FDA Panel Vote, Pacific Biosciences Sinks On Q1 Miss Benzinga
May-02-18 05:46PM  Pacific Biosciences: 1Q Earnings Snapshot Associated Press
04:01PM  Pacific Biosciences of California, Inc. Announces First Quarter 2018 Financial Results GlobeNewswire
Apr-27-18 08:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Bottomline Technologies, SkyWest, Pacific Biosciences of California, Argos Therapeutics, Luminex, and Fiserv New Research Emphasizes Economic Growth GlobeNewswire
Apr-24-18 01:00PM  GENEWIZ And Pacific Biosciences Announce Winner Of The 2017 Structural Variant SMRT® Grant Program PR Newswire
Apr-20-18 07:37PM  Pacific Biosciences of California, Inc. First Quarter 2018 Financial Results Call GlobeNewswire
Apr-12-18 06:00PM  Pacific Biosciences Gains as HudsonAlpha Picks Sequel System Zacks
Apr-11-18 07:30AM  HudsonAlpha Using PacBio Sequencing for Childhood Developmental Disabilities Research GlobeNewswire
Mar-27-18 07:30AM  Pacific Biosciences Announces Ten-Unit Sequel System Order for Annoroad GlobeNewswire
Mar-22-18 04:35PM  Pacific Biosciences Prevails in Patent Eligibility Ruling Against Oxford Nanopore GlobeNewswire
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company's single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. It offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes single molecule biochemical reactions in real time. The company also provides consumable products, including SMRT cells, as well as various reagent kits, such as template preparation, binding, and sequencing kits. Its customers include research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. The company markets its products through a direct sales force in North America and Europe, as well as primarily through distribution partners in Asia, the Middle East, and Latin America. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARNES SUSAN KEVP, CFO and PAODec 20Option Exercise4.28316,9901,356,129708,157Dec 21 04:37 PM
ORDONEZ KATHYChief Commercial OfficerNov 27Option Exercise2.9025,00072,50068,750Nov 28 04:03 PM
ORDONEZ KATHYChief Commercial OfficerNov 27Sale7.5425,000188,50043,750Nov 28 04:03 PM